USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS (Q4244517)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 1292936
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS |
scientific article; zbMATH DE number 1292936 |
Statements
USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS (English)
0 references
5 September 1999
0 references
interim analyses
0 references
therapeutic equivalence
0 references
beta-binomial distribution
0 references
0.7507492899894714
0 references
0.746604323387146
0 references
0.7293751835823059
0 references
0.7197756171226501
0 references
0.6996734738349915
0 references
